Connection

Armen Gasparyan to Betacoronavirus

Back to Details
This is a "connection" page, showing publications Armen Gasparyan has written about Betacoronavirus.
Armen Gasparyan
Connection Strength
0.055
Betacoronavirus
  1. Diversifying online rheumatology education options in the era of COVID-19. Clin Rheumatol. 2020 12; 39(12):3533-3534.
    View in: PubMed
    Score: 0.010
  2. Moving towards online rheumatology education in the era of COVID-19. Clin Rheumatol. 2020 Nov; 39(11):3215-3222.
    View in: PubMed
    Score: 0.010
  3. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int. 2020 11; 40(11):1741-1751.
    View in: PubMed
    Score: 0.010
  4. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020 Sep; 39(9):2529-2543.
    View in: PubMed
    Score: 0.009
  5. Perspectives of Immune Therapy in Coronavirus Disease 2019. J Korean Med Sci. 2020 May 11; 35(18):e176.
    View in: PubMed
    Score: 0.009
  6. Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists. Rheumatol Int. 2020 12; 40(12):2023-2030.
    View in: PubMed
    Score: 0.002
  7. Information and Misinformation on COVID-19: a Cross-Sectional Survey Study. J Korean Med Sci. 2020 Jul 13; 35(27):e256.
    View in: PubMed
    Score: 0.002
  8. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020 Jul; 39(7):2055-2062.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.